MedTrace Logo

Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses

NCT03919396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2023-03-01

No results posted yet for this study

Summary

This is a 24-month longitudinal randomized controlled trial aiming to evaluate the effectiveness of myopia control by Breath-O correct orthokeratology lenses in different myopia progression groups classified according to their initial electro-retinal responses.

Conditions

  • Myopia
  • Orthokeratology

Interventions

DEVICE

Breath-O orthokeratology lenses

Specially designed rigid gas permeable lenses which 1. reshapes corneal profile for myopia control 2. has higher elasticity compared to traditional lens material.

Sponsors & Collaborators

  • SEED Co. Ltd.

    collaborator UNKNOWN

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Henry HL Chan, PhD · The Hong Kong Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-10-31
Completion
2022-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03919396 on ClinicalTrials.gov